Related Experiment Video
Updated: May 2, 2026

Production of Double-stranded DNA Ministrings
Published on: February 29, 2016
Nonviral DNA delivery's recent successes and final hurdles
Sachchidanand Tiwari1, Manthan N Patel2, Jacob S Brenner2
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract:
Nonviral DNA delivery has emerged as a promising alternative to viral vectors for gene therapy because of its reduced immunogenicity, scalable manufacturing, and capability of loading larger cargos. Despite these advantages, multiple hurdles must be addressed. The endosomal barrier poses a significant obstacle because DNA is often degraded in acidic vesicles following endocytosis. After endosomal release, DNA is sensed by the cyclic GMP-AMP synthase, a cytosolic immune sensor, leading to inflammation and lower gene expression levels. Furthermore, DNA requires nuclear entry for gene expression, which has been one of the most complex challenges for the field to progress. Recent advances have explored innovative strategies to overcome these hurdles for nonviral DNA delivery. This review highlights the current landscape of nonviral DNA delivery, focusing on intracellular barriers and recent technological breakthroughs. We further discuss future directions to overcome these challenges to develop safe, effective, and clinically translatable nonviral DNA delivery systems for a range of therapeutic applications. SIGNIFICANCE STATEMENT: Nonviral DNA delivery offers a safer, scalable alternative to viral vectors but faces key challenges such as endosomal escape, poor tolerability, and low levels of transgene expression. This review highlights the critical barriers and emerging solutions, outlining how recent advances can enable low-cost, redosable genetic medicine and DNA vaccines suited for clinical translation.
More Related Videos
09:23Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"
Published on: March 31, 2021
06:10Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
Related Concept Videos
Retrovirus Life Cycles
Viral Recombination
Viral Mutations
Viral Replication: Lytic Cycle
Viral Replication: Lysogenic Cycle
Viruses with RNA Genomes